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340 Is cystic ﬁbrosis survival improving in excess to that of the
general population for England and Wales and the USA?
M.N. Hurley1, T. McKeever2, A.P. Prayle1, A. Fogarty2, A.R. Smyth1. 1University
of Nottingham, Division of Child Health, Nottingham, United Kingdom; 2University
of Nottingham, Division of Epidemiology and Public Health, Nottingham, United
Kingdom
Objectives: The survival of those with cystic ﬁbrosis (CF) is improving and a
median survival over 50 years for those born since 2000 has been predicted. It
is assumed that such improvements in survival have been due to improvements in
care. We tested the alternative hypothesis that improvements in CF survival simply
reﬂect improving life expectancy of the general population.
Methods: Mortality data for each year by cause of death and gender were retrieved
from the Ofﬁce of National Statistics for England and Wales (E&W) (1968–2009)
and Centers for Disease Control and Prevention WONDER for the USA (1979–
2007). Median age at death was interpolated for each group. The absolute difference
between groups over time was calculated and a regression model constructed to
explore the relationship between series over time.
Conclusions: The all-cause survival in E&W was better than in the US over
5 decades. CF survival was better in the USA compared to E&W, and better
for males compared to females in both countries. The difference in median
survival between all-cause mortality and CF mortality is narrowing over time by
between 0.26–0.36 life years per year (males in E&W difference coefﬁcient −0.367;
p< 0.001) as is the difference in CF survival between the USA and E&W (difference
coefﬁcient, males −0.074; p = 0.038). The difference in survival between males and
females with CF does not appear to be reducing. The steady increase in survival of
those with CF cannot be accounted for simply by improvements in living conditions
and health experienced by the general population but must in part be attributable
to advances in the medical care of people with CF.
341 Do too few children with cystic ﬁbrosis participate in clinical
research?
A.P. Prayle1, M.N. Hurley1, A.R. Smyth1. 1University of Nottingham, Child
Health, E Floor East Block, Nottingham, United Kingdom
Objectives: Recently multiple new therapies have entered clinical trials which aim
to correct the basic defect in patients with cystic ﬁbrosis (CF). Trials of these new
therapies will be particularly important in the early years of life prior to irreversible
lung damage. We investigated the effect of age upon trial participation.
Methods: Using anonymized data for each patient in the UK CF Registry from
2009, we examined the relationship between patient age, sex, and clinic size upon
participation in clinical trials. The proportion of paediatric patients taking part in
clinical trials was compared to adults. A robust multivariate regression model was
used to investigate the link between size of centre trial participation.
Results: In 2009, 762/7377 (10.3%) patients were recorded as taking part in a
clinical trial. Participation amongst adult patients (14.5%) was greater than amongst
children under 18 years (5.5%). More males took part than females (5.9% vs 4.4%),
however after adjusting for age, sex was not associated with participation in clinical
trials (p = 0.09), but age remained signiﬁcant (p = 2.2×10−16).
Paediatric centres were smaller than adult centres (Wilcoxon test p = 0.003). In a
robust linear multi-variable model, size of centre was associated with the proportion
of patients in that centre who participated in clinical research (p = 0.031), but type
of centre (paediatric vs adult) was not (p = 0.746).
Conclusions: Adults are more likely than children to take part in research. As
paediatric centres tend to be smaller than adult centres, increasing research in
smaller clinics should increase the number of paediatric patients participating in
clinical research.
342 Inﬂuence of parents’ incomes and education level on the clinical
state in CF
G.J. Casimir1, L. Hanssens1, C. Goossens1, C. Knoop1. 1Universite´ Libre de
Bruxelles, Brussels, Belgium
Several studies showed that the prognosis of cystic ﬁbrosis is in part dependent on
socio-economical factors. This is also true for the educational levels of the parents
and in particular of the mother which inﬂuences the future of the child.
Objectives: Evaluate the role of economical and educational factors in parents on
the clinical status of the CF child.
Methods: We have studied 73 CF patients, aged from 1 to 25 years, according to
social and educational criteria speciﬁed by questionnaires and analyzed the answers
according to clinical and biological data from the cases report forms.
Results: Gender inﬂuences nutritional status (lower percentile of weight and BMI in
girls p< 0.009) and respiratory function (lower FEV1 in girls, p< 0.05) especially in
families with low incomes and low educational level. The frequency of antibiotic
administrations is higher (p< 0.03) and the ﬁrst colonization by Staphylococcus
earlier (p< 0.02) in case of low incomes.
Conclusions: We must consider socio-economical conditions and education level
as important factors for the clinical status of our patients and try to reduce their
negative role.
343 Transplantation in CF patients in the French CF Registry
L. Lemonnier1, S. Ravilly2, G. Bellis3. 1Vaincre la Mucoviscidose, Me´dical, Paris,
France; 2Vaincre la Mucoviscidose, Paris, France; 3INED, Paris, France
In 2009, the French CF Registry registered 400 transplant recipients (7% of the CF
population). In France, a new lung allocation program was implemented in 2007,
increasing the proportion of lung transplanted CF patients.
Objectives: To describe the evolution of transplantation in the CF population
between 1988 and 2010.
Methods: Patients were separated into 4 cohorts according to the year of trans-
plantation (1988–1995, 1996–2000, 2001–2005, 2006–2010). The ANOVA method
was used for the comparisons between the cohorts.
Results: A total of 740 patients received one (N= 664) or 2 (N= 76) transplan-
tations, representing 792 transplantations.
The male–female ratio was 97. A signiﬁcant increase in mean age is observed
between the two most recent cohorts: 25.9 years (N = 240) and 26.9 years (N = 391)
and the oldest one: 19.3 years (N = 60), p< 0.05, even though the numbers of
paediatric transplantations have increased during the period (25, 29, 35, 43).
Heart–lung transplantation (N= 78) remained steady between 1990 and 2005 (2 to 5
per year) and has become rare since 2006. On the other hand, double-lung
transplantation (N= 639) increased (13 in 2000, 75 in 2009).
Thoracic transplant recipients receiving a kidney transplant (N = 24) become more
frequent. Mean duration between the two transplantations is 8.6±4.1 years. With the
increase in post transplant survival, the risk of terminal renal failure is increasing.
Conclusions: The proportion of transplantations, mostly double-lung, has been
increasing during the last 20 years (in 2009, 24% of the CF patients aged
30−39 years were transplant recipients). Mean age at transplantation is increasing
signiﬁcantly, probably thanks to a better medical care.
